BPC-157
Synthetic gastric pentadecapeptide research reference · preclinical evidence predominates
- Purity
- Target ≥ 99.0% · Batch COA
- CAS
- 137525-51-0
Research categories
Scientific identifiers, sequences and source publication titles are retained in their original form.
Synthetic gastric pentadecapeptide research reference · preclinical evidence predominates
Copper(II)-complexed GHK tripeptide · supplied form and copper stoichiometry are procurement-critical
Full-length thymosin-β4 (43 residues, N-acetylated) research reference
BPC-157 + full-length thymosin-β4 (TB-500) two-peptide research pairing · no established biological synergy
Unvalidated Three-Component Research Blend / BPC-157 + TB-500 (Thymosin Beta-4, full-length) + GHK-Cu
PEG-conjugated MGF E-peptide research material · architecture must be defined by lot
N-acetylated thymosin-β4 residues 17–23 research fragment · not full-length thymosin-β4